Archimedes gets OK for fentanyl nasal spray
Archimedes Pharma Ltd. and its subsidiary Archimedes Pharma U.S. Inc. have been cleared by the U.S. Food and Drug Administration to market approved Lazanda (fentanyl) nasal spray, for the management of breakthrough pain in cancer patients.